88931-51-5

Basic information

• Product Name: (1S,5R,6R,7R)-5-[7-Hydroxy-6-[3(S)-hydroxy-1(E)-octenyl]bicyclo[3.3.0]oct-2-en-3-yl]pentanoic acid methyl ester
• Synonyms: Clinprost; Lipo-isocarbacyclin methyl ester; Lipo PGI2; TEI-9090; TTC-909(lipid microsphere formulation); Lipocurren; Arteon; (+)-(3aS,5R,6R,6aS)-1,3a,4,5,6,6a-Hexahydro-5-hydroxy-6-[3(S)-hydroxy-1(E)-octenyl]-2-pentalenevaleric acid methyl ester; methyl 5-{(3aS,5R,6R,6aS)-5-hydroxy-6-[(1E,3R)-3-hydroxyoct-1-en-1-yl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl}pentanoate; methyl 5-{(3aS,5R,6R,6aS)-5-hydroxy-6-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl}pentanoate
• CAS NO: 88931-51-5
• Molecular Formula: C₂₂H₃₆O₄
• Molecular Weight: 364.5188
• Mol File: 88931-51-5.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 469.2°C at 760 mmHg
• Flash Point: 151.9°C
• Density: 1.089g/cm³
• Vapor Pressure: 8.97E-11mmHg at 25°C
• Refractive Index: 1.547
• CAS DataBase Reference: (1S,5R,6R,7R)-5-[7-Hydroxy-6-[3(S)-hydroxy-1(E)-octenyl]bicyclo[3.3.0]oct-2-en-3-yl]pentanoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (1S,5R,6R,7R)-5-[7-Hydroxy-6-[3(S)-hydroxy-1(E)-octenyl]bicyclo[3.3.0]oct-2-en-3-yl]pentanoic acid methyl ester(88931-51-5)
• EPA Substance Registry System: (1S,5R,6R,7R)-5-[7-Hydroxy-6-[3(S)-hydroxy-1(E)-octenyl]bicyclo[3.3.0]oct-2-en-3-yl]pentanoic acid methyl ester(88931-51-5)

Safety Data

• Hazardous Substances Data: 88931-51-5(Hazardous Substances Data)

Upstream product

• 88911-33-5 5-{(3aR,5S,6S,6aR)-5-(Tetrahydro-pyran-2-yloxy)-6-[(E)-(R)-3-(tetrahydro-pyran-2-yloxy)-oct-1-enyl]-1,3a,4,5,6,6a-hexahydro-pentalen-2-yl}-pentanoic acid methyl ester 
• 98676-84-7 11,15-O-bis(t-butyldimethylsilyl)-9(O)-methano-Δ^6(9α)-prostaglandin I₁ methyl ester 
• 110972-06-0 <3aS-<3aα,4α(1E,3R^*),5β,6aα>>-methyl 5-pentanoate 
• 88911-33-5 5-{(3aS,5R,6R,6aS)-5-(Tetrahydro-pyran-2-yloxy)-6-[(E)-3-(tetrahydro-pyran-2-yloxy)-oct-1-enyl]-1,3a,4,5,6,6a-hexahydro-pentalen-2-yl}-pentanoic acid methyl ester 
• 91078-27-2 methyl (1R,5S,6R,7R)-7-tert-butyldimethylsilyloxy-6-(3-hydroxy-(E)-1-octenyl)bicyclo<3.3.0>oct-2-ene-3-pentanoate 
• 72397-64-9 (1S*,5S*,7R*,8R*)-7-tert-butyldimethylsilyloxy-8-(3-tert-butyldimethylsilyloxy-E-1-octenyl)bicyclo<3.3.0>octan-2-one 
• 88911-31-3 5-{(3aS,4R,5R,6aS)-2-Hydroxy-1-methanesulfonyloxy-5-(tetrahydro-pyran-2-yloxy)-4-[(E)-3-(tetrahydro-pyran-2-yloxy)-oct-1-enyl]-octahydro-pentalen-2-yl}-pentanoic acid methyl ester 
• 110456-28-5 7-{(1S,2R,3R,5S)-5-Hydroxymethyl-3-(tetrahydro-pyran-2-yloxy)-2-[(E)-3-(tetrahydro-pyran-2-yloxy)-oct-1-enyl]-cyclopentyl}-6-oxo-heptanoic acid methyl ester 
• 110456-29-6 7-{(1R,2R,3R,5S)-5-Formyl-3-(tetrahydro-pyran-2-yloxy)-2-[(E)-3-(tetrahydro-pyran-2-yloxy)-oct-1-enyl]-cyclopentyl}-6-oxo-heptanoic acid methyl ester 
• 69170-69-0 5-[(4aS,5R,6R,7aS)-6-(Tetrahydro-pyran-2-yloxy)-5-[(E)-3-(tetrahydro-pyran-2-yloxy)-oct-1-enyl]-hexahydro-cyclopenta[c]pyran-(3E)-ylidene]-pentanoic acid methyl ester 
• 110456-27-4 (Z)-7-{(1S,2R,3R,5S)-5-Hydroxymethyl-3-(tetrahydro-pyran-2-yloxy)-2-[(E)-3-(tetrahydro-pyran-2-yloxy)-oct-1-enyl]-cyclopentyl}-hept-5-enoic acid methyl ester 
• 88911-30-2 5-{(3aS,4R,5R,6aS)-1,2-Dihydroxy-5-(tetrahydro-pyran-2-yloxy)-4-[(E)-3-(tetrahydro-pyran-2-yloxy)-oct-1-enyl]-octahydro-pentalen-2-yl}-pentanoic acid methyl ester 
• 88911-32-4 5-{(1bS,3R,4R,4aS)-3-(Tetrahydro-pyran-2-yloxy)-4-[(E)-3-(tetrahydro-pyran-2-yloxy)-oct-1-enyl]-hexahydro-1-oxa-cyclopropa[a]pentalen-5a-yl}-pentanoic acid methyl ester 
• 53232-40-9 (Z)-7-{(1R,2R,3R)-5-Oxo-3-(tetrahydro-pyran-2-yloxy)-2-[(E)-3-(tetrahydro-pyran-2-yloxy)-oct-1-enyl]-cyclopentyl}-hept-5-enoic acid methyl ester 

Downstream Products

• 141978-79-2 5-[(3aS,5R,6R,6aS)-6-[(E)-(S)-7-(3-Azido-phenyl)-3-hydroxy-hept-1-enyl]-5-(tert-butyl-dimethyl-silanyloxy)-1,3a,4,5,6,6a-hexahydro-pentalen-2-yl]-pentanoic acid methyl ester 
• 141887-99-2 5-[(3aS,5R,6R,6aS)-6-[(E)-(R)-7-(3-Azido-phenyl)-3-hydroxy-hept-1-enyl]-5-(tert-butyl-dimethyl-silanyloxy)-1,3a,4,5,6,6a-hexahydro-pentalen-2-yl]-pentanoic acid methyl ester 
• 141978-77-0 19-(3-azidophenyl)-20-norisocarbacyclin methyl ester 
• 141887-95-8 5-{(3aS,5R,6R,6aS)-6-[(E)-(R)-7-(3-Azido-phenyl)-3-hydroxy-hept-1-enyl]-5-hydroxy-1,3a,4,5,6,6a-hexahydro-pentalen-2-yl}-pentanoic acid methyl ester 
• 141887-85-6 5-{(1R,2R,3S,5R,6R,7R)-2-Iodo-6-[(E)-(S)-7-phenyl-3-((S)-3,3,3-trifluoro-2-methoxy-2-phenyl-propionyloxy)-hept-1-enyl]-9-oxa-tricyclo[3.3.1.0^3,7]non-1-yl}-pentanoic acid methyl ester 
• 141887-88-9 5-[(3aS,5R,6R,6aS)-6-[(E)-7-(3-Azido-phenyl)-3-oxo-hept-1-enyl]-5-(tert-butyl-dimethyl-silanyloxy)-1,3a,4,5,6,6a-hexahydro-pentalen-2-yl]-pentanoic acid methyl ester 
• 141887-97-0 5-[(1R,2R,3S,5R,6S,7R)-2-Iodo-6-((S)-3,3,3-trifluoro-2-methoxy-2-phenyl-propionyloxymethyl)-9-oxa-tricyclo[3.3.1.0^3,7]non-1-yl]-pentanoic acid methyl ester 
• 141887-98-1 5-[(1S,3S,4S,5R,7R)-4-((S)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionyloxymethyl)-9-oxa-tricyclo[3.3.1.0^3,7]non-1-yl]-pentanoic acid methyl ester 
• 140900-69-2 19-(3-azidophenyl)-15-dehydro-20-norisocarbacyclin methyl ester 
• 141887-92-5 17-(4-azidophenyl)-15-dehydro-18,19,20-trinorisocarbacyclin methyl ester 
• 141887-79-8 17-(3-azidophenyl)-15-dehydro-18,19,20-trinorisocarbacyclin methyl ester 
• 141887-82-3 5-{(3aS,5R,6R,6aS)-6-[(E)-(S)-7-(3-Amino-phenyl)-3-hydroxy-hept-1-enyl]-5-hydroxy-1,3a,4,5,6,6a-hexahydro-pentalen-2-yl}-pentanoic acid methyl ester 
• 141887-96-9 5-{(3aS,5R,6R,6aS)-6-[(S)-7-(3-Amino-phenyl)-3-hydroxy-heptyl]-5-hydroxy-1,3a,4,5,6,6a-hexahydro-pentalen-2-yl}-pentanoic acid methyl ester 
• 141887-84-5 5-[(1R,2R,3S,5R,6R,7R)-6-((E)-(S)-3-Hydroxy-7-phenyl-hept-1-enyl)-2-iodo-9-oxa-tricyclo[3.3.1.0^3,7]non-1-yl]-pentanoic acid methyl ester 

Relevant articles and documents

Synthesis of tritium-labelled isocarbacyclin derivatives, radiolabelled prostaglandin I1 analogs(1)

Three tritiated isocarbacyclin [9 (O) -metano-Δ6(9α) - prostaglandin I1] derivatives, [11-3H]-isocarbacyclin methyl ester (7a), [11-3H] - (17S)-17-methyl-20-homoisocarbacyclin (9), and its methyl ester (8a) were synthesized. Tritium was introduced to the 11-position via [3H]-sodium tetrahydroborate reduction of 11-dehydro-isocarbacyclin intermediates 10 and 11.

Efficient synthesis of isocarbacyclins

-

Isocarbacyclin derivatives and process for production thereof

An isocarbacyclin derivative represented by the general formula STR1 wherein R1 represents a linear, branched or cyclic alkyl, alkenyl or alkynyl group having 5 to 10 carbon atoms, and R2 and R3 represent a hydrogen atom or a protective group for the hydroxyl group; and a process for production thereof.